Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Piper Sandler to hold a virtual conference » 04:55
12/02/21
12/02
04:55
12/02/21
04:55
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$5.67 /

-0.24 (-4.06%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$36.93 /

-2.49 (-6.32%)

, CUE

Cue Biopharma

$11.46 /

-0.795 (-6.49%)

, DOCS

Doximity

$64.67 /

-2.945 (-4.36%)

, DMAC

DiaMedica Therapeutics

$3.70 /

+ (+0.00%)

, DICE

Dice Therapeutics

$31.07 /

-0.62 (-1.96%)

, FLDM

Fluidigm

$4.40 /

-0.22 (-4.76%)

, GBT

Global Blood Therapeutics

$27.14 /

-1.16 (-4.10%)

, IMTX

Immatics

$11.19 /

-0.2 (-1.76%)

, HALO

Halozyme

$32.19 /

-0.72 (-2.19%)

, IOVA

Iovance Biotherapeutics

$17.60 /

-1.12 (-5.98%)

, MDXG

MiMedx

$6.92 /

-0.075 (-1.07%)

, NUVA

NuVasive

$47.98 /

-0.04 (-0.08%)

, ONTX

Onconova

$2.74 /

-0.265 (-8.82%)

, PSNL

Personalis

$13.06 /

-0.56 (-4.11%)

, QDEL

Quidel

$144.74 /

-2.76 (-1.87%)

, REGN

Regeneron

$630.74 /

-5.67 (-0.89%)

, RVNC

Revance

$14.21 /

+0.51 (+3.72%)

, SEER

Seer

$21.09 /

-1.18 (-5.30%)

, SNSE

Sensei Biotherapeutics

$6.78 /

-0.11 (-1.60%)

, TFX

Teleflex

$289.46 /

-7.82 (-2.63%)

, TNYA

Tenaya Therapeutics

$19.59 /

-0.28 (-1.41%)

, VIVO

Meridian Bioscience

$19.59 /

-0.33 (-1.66%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

TFX Teleflex
$289.46 /

-7.82 (-2.63%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

SEER Seer
$21.09 /

-1.18 (-5.30%)

RVNC Revance
$14.21 /

+0.51 (+3.72%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

PSNL Personalis
$13.06 /

-0.56 (-4.11%)

ONTX Onconova
$2.74 /

-0.265 (-8.82%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

MDXG MiMedx
$6.92 /

-0.075 (-1.07%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

IMTX Immatics
$11.19 /

-0.2 (-1.76%)

HALO Halozyme
$32.19 /

-0.72 (-2.19%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

CUE Cue Biopharma
$11.46 /

-0.795 (-6.49%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.67 /

-0.24 (-4.06%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$5.67 /

-0.24 (-4.06%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

12/01/21 Mizuho
Cytokinetics price target raised to $54 from $45 at Mizuho
11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
CUE Cue Biopharma
$11.46 /

-0.795 (-6.49%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

12/01/21 Jefferies
Doximity initiated with a Buy at Jefferies
11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.19 /

-0.2 (-1.76%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$32.19 /

-0.72 (-2.19%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$6.92 /

-0.075 (-1.07%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$2.74 /

-0.265 (-8.82%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.06 /

-0.56 (-4.11%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$144.74 /

-2.76 (-1.87%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$630.74 /

-5.67 (-0.89%)

11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
RVNC Revance
$14.21 /

+0.51 (+3.72%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$21.09 /

-1.18 (-5.30%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$289.46 /

-7.82 (-2.63%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$19.59 /

-0.28 (-1.41%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

TNYA Tenaya Therapeutics
$19.59 /

-0.28 (-1.41%)

TFX Teleflex
$289.46 /

-7.82 (-2.63%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

SEER Seer
$21.09 /

-1.18 (-5.30%)

RVNC Revance
$14.21 /

+0.51 (+3.72%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

PSNL Personalis
$13.06 /

-0.56 (-4.11%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

IMTX Immatics
$11.19 /

-0.2 (-1.76%)

HALO Halozyme
$32.19 /

-0.72 (-2.19%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

CUE Cue Biopharma
$11.46 /

-0.795 (-6.49%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.67 /

-0.24 (-4.06%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$21.09 /

-1.18 (-5.30%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

VIVO Meridian Bioscience
$19.59 /

-0.33 (-1.66%)

TNYA Tenaya Therapeutics
$19.59 /

-0.28 (-1.41%)

TFX Teleflex
$289.46 /

-7.82 (-2.63%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.11 (-1.60%)

SEER Seer
$21.09 /

-1.18 (-5.30%)

RVNC Revance
$14.21 /

+0.51 (+3.72%)

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

QDEL Quidel
$144.74 /

-2.76 (-1.87%)

PSNL Personalis
$13.06 /

-0.56 (-4.11%)

ONTX Onconova
$2.74 /

-0.265 (-8.82%)

NUVA NuVasive
$47.98 /

-0.04 (-0.08%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

HALO Halozyme
$32.19 /

-0.72 (-2.19%)

GBT Global Blood Therapeutics
$27.14 /

-1.16 (-4.10%)

FLDM Fluidigm
$4.40 /

-0.22 (-4.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

DMAC DiaMedica Therapeutics
$3.70 /

+ (+0.00%)

DICE Dice Therapeutics
$31.07 /

-0.62 (-1.96%)

CYTK Cytokinetics
$36.93 /

-2.49 (-6.32%)

BXRX Baudax Bio
/

+

REGN Regeneron
$630.74 /

-5.67 (-0.89%)

IOVA Iovance Biotherapeutics
$17.60 /

-1.12 (-5.98%)

IMTX Immatics
$11.19 /

-0.2 (-1.76%)

DOCS Doximity
$64.67 /

-2.945 (-4.36%)

Wednesday
Conference/Events
Piper Sandler to hold a virtual conference » 04:55
12/01/21
12/01
04:55
12/01/21
04:55
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$5.91 /

-0.16 (-2.64%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$39.30 /

+0.51 (+1.31%)

, CUE

Cue Biopharma

$12.27 /

+0.24 (+2.00%)

, DOCS

Doximity

$67.60 /

+0.91 (+1.36%)

, DMAC

DiaMedica Therapeutics

$3.69 /

+0.05 (+1.37%)

, DICE

Dice Therapeutics

$31.69 /

+0.21 (+0.67%)

, FLDM

Fluidigm

$4.62 /

+0.115 (+2.55%)

, GBT

Global Blood Therapeutics

$28.30 /

+0.31 (+1.11%)

, IMTX

Immatics

$11.39 /

+0.07 (+0.62%)

, HALO

Halozyme

$32.89 /

-0.425 (-1.28%)

, IOVA

Iovance Biotherapeutics

$18.70 /

+0.445 (+2.44%)

, MDXG

MiMedx

$7.00 /

-0.155 (-2.17%)

, NUVA

NuVasive

$48.02 /

-1.19 (-2.42%)

, ONTX

Onconova

$3.01 /

-0.05 (-1.63%)

, PSNL

Personalis

$13.58 /

-0.175 (-1.27%)

, QDEL

Quidel

$147.25 /

-2.36 (-1.58%)

, REGN

Regeneron

$636.37 /

-17.98 (-2.75%)

, RVNC

Revance

$13.69 /

+1.24 (+9.96%)

, SEER

Seer

$22.29 /

+0.76 (+3.53%)

, SNSE

Sensei Biotherapeutics

$6.93 /

+0.16 (+2.36%)

, TFX

Teleflex

$297.56 /

-11.39 (-3.69%)

, TNYA

Tenaya Therapeutics

$19.87 /

+1.17 (+6.26%)

, VIVO

Meridian Bioscience

$19.91 /

-0.17 (-0.85%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

TFX Teleflex
$297.56 /

-11.39 (-3.69%)

SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

SEER Seer
$22.29 /

+0.76 (+3.53%)

RVNC Revance
$13.69 /

+1.24 (+9.96%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

PSNL Personalis
$13.58 /

-0.175 (-1.27%)

ONTX Onconova
$3.01 /

-0.05 (-1.63%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

MDXG MiMedx
$7.00 /

-0.155 (-2.17%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

IMTX Immatics
$11.39 /

+0.07 (+0.62%)

HALO Halozyme
$32.89 /

-0.425 (-1.28%)

GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

CUE Cue Biopharma
$12.27 /

+0.24 (+2.00%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.91 /

-0.16 (-2.64%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/30/21 SVB Leerink
Abeona Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$5.91 /

-0.16 (-2.64%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CUE Cue Biopharma
$12.27 /

+0.24 (+2.00%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
11/10/21 Canaccord
Doximity price target raised to $75 from $70 at Canaccord
DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.39 /

+0.07 (+0.62%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$32.89 /

-0.425 (-1.28%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$7.00 /

-0.155 (-2.17%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$3.01 /

-0.05 (-1.63%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.58 /

-0.175 (-1.27%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$147.25 /

-2.36 (-1.58%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$636.37 /

-17.98 (-2.75%)

11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
RVNC Revance
$13.69 /

+1.24 (+9.96%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$22.29 /

+0.76 (+3.53%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$297.56 /

-11.39 (-3.69%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$19.87 /

+1.17 (+6.26%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

TNYA Tenaya Therapeutics
$19.87 /

+1.17 (+6.26%)

TFX Teleflex
$297.56 /

-11.39 (-3.69%)

SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

SEER Seer
$22.29 /

+0.76 (+3.53%)

RVNC Revance
$13.69 /

+1.24 (+9.96%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

PSNL Personalis
$13.58 /

-0.175 (-1.27%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

IMTX Immatics
$11.39 /

+0.07 (+0.62%)

HALO Halozyme
$32.89 /

-0.425 (-1.28%)

GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

CUE Cue Biopharma
$12.27 /

+0.24 (+2.00%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$5.91 /

-0.16 (-2.64%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$22.29 /

+0.76 (+3.53%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

VIVO Meridian Bioscience
$19.91 /

-0.17 (-0.85%)

TNYA Tenaya Therapeutics
$19.87 /

+1.17 (+6.26%)

TFX Teleflex
$297.56 /

-11.39 (-3.69%)

SNSE Sensei Biotherapeutics
$6.93 /

+0.16 (+2.36%)

SEER Seer
$22.29 /

+0.76 (+3.53%)

RVNC Revance
$13.69 /

+1.24 (+9.96%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

QDEL Quidel
$147.25 /

-2.36 (-1.58%)

PSNL Personalis
$13.58 /

-0.175 (-1.27%)

ONTX Onconova
$3.01 /

-0.05 (-1.63%)

NUVA NuVasive
$48.02 /

-1.19 (-2.42%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

HALO Halozyme
$32.89 /

-0.425 (-1.28%)

GBT Global Blood Therapeutics
$28.30 /

+0.31 (+1.11%)

FLDM Fluidigm
$4.62 /

+0.115 (+2.55%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

DMAC DiaMedica Therapeutics
$3.69 /

+0.05 (+1.37%)

DICE Dice Therapeutics
$31.69 /

+0.21 (+0.67%)

CYTK Cytokinetics
$39.30 /

+0.51 (+1.31%)

BXRX Baudax Bio
/

+

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

IOVA Iovance Biotherapeutics
$18.70 /

+0.445 (+2.44%)

IMTX Immatics
$11.39 /

+0.07 (+0.62%)

DOCS Doximity
$67.60 /

+0.91 (+1.36%)

Tuesday
Conference/Events
Piper Sandler to hold a virtual conference » 04:55
11/30/21
11/30
04:55
11/30/21
04:55
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$6.07 /

-0.29 (-4.56%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$38.79 /

-0.38 (-0.97%)

, CUE

Cue Biopharma

$12.03 /

-0.86 (-6.67%)

, DOCS

Doximity

$66.69 /

+5.56 (+9.10%)

, DMAC

DiaMedica Therapeutics

$3.63 /

-0.135 (-3.59%)

, DICE

Dice Therapeutics

$31.39 /

-1.68 (-5.08%)

, FLDM

Fluidigm

$4.51 /

-0.195 (-4.15%)

, GBT

Global Blood Therapeutics

$27.99 /

-1.375 (-4.68%)

, IMTX

Immatics

$11.33 /

+0.05 (+0.44%)

, HALO

Halozyme

$33.31 /

-0.61 (-1.80%)

, IOVA

Iovance Biotherapeutics

$18.26 /

-0.23 (-1.24%)

, MDXG

MiMedx

$7.14 /

-0.2 (-2.72%)

, NUVA

NuVasive

$49.21 /

-1.4 (-2.77%)

, ONTX

Onconova

$3.06 /

-0.11 (-3.47%)

, PSNL

Personalis

$13.74 /

-0.27 (-1.93%)

, QDEL

Quidel

$149.61 /

+5.01 (+3.46%)

, REGN

Regeneron

$654.26 /

+9.38 (+1.45%)

, RVNC

Revance

$12.45 /

-0.4 (-3.11%)

, SEER

Seer

$21.53 /

-1.37 (-5.98%)

, SNSE

Sensei Biotherapeutics

$6.78 /

-0.79 (-10.44%)

, TFX

Teleflex

$308.95 /

+4 (+1.31%)

, TNYA

Tenaya Therapeutics

$18.70 /

-0.62 (-3.21%)

, VIVO

Meridian Bioscience

$20.11 /

-0.09 (-0.45%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

TFX Teleflex
$308.95 /

+4 (+1.31%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

SEER Seer
$21.53 /

-1.37 (-5.98%)

RVNC Revance
$12.45 /

-0.4 (-3.11%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

PSNL Personalis
$13.74 /

-0.27 (-1.93%)

ONTX Onconova
$3.06 /

-0.11 (-3.47%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

MDXG MiMedx
$7.14 /

-0.2 (-2.72%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

IMTX Immatics
$11.33 /

+0.05 (+0.44%)

HALO Halozyme
$33.31 /

-0.61 (-1.80%)

GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

CUE Cue Biopharma
$12.03 /

-0.86 (-6.67%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.07 /

-0.29 (-4.56%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$6.07 /

-0.29 (-4.56%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CUE Cue Biopharma
$12.03 /

-0.86 (-6.67%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
11/10/21 Canaccord
Doximity price target raised to $75 from $70 at Canaccord
DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.33 /

+0.05 (+0.44%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$33.31 /

-0.61 (-1.80%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$7.14 /

-0.2 (-2.72%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$3.06 /

-0.11 (-3.47%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.74 /

-0.27 (-1.93%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$149.61 /

+5.01 (+3.46%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$654.26 /

+9.38 (+1.45%)

11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
11/09/21 Benchmark
Benchmark sees signs Regeneron may be planning large acquisition
RVNC Revance
$12.45 /

-0.4 (-3.11%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$21.53 /

-1.37 (-5.98%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$308.95 /

+4 (+1.31%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$18.70 /

-0.62 (-3.21%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

TNYA Tenaya Therapeutics
$18.70 /

-0.62 (-3.21%)

TFX Teleflex
$308.95 /

+4 (+1.31%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

SEER Seer
$21.53 /

-1.37 (-5.98%)

RVNC Revance
$12.45 /

-0.4 (-3.11%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

PSNL Personalis
$13.74 /

-0.27 (-1.93%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

IMTX Immatics
$11.33 /

+0.05 (+0.44%)

HALO Halozyme
$33.31 /

-0.61 (-1.80%)

GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

CUE Cue Biopharma
$12.03 /

-0.86 (-6.67%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.07 /

-0.29 (-4.56%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$21.53 /

-1.37 (-5.98%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

VIVO Meridian Bioscience
$20.11 /

-0.09 (-0.45%)

TNYA Tenaya Therapeutics
$18.70 /

-0.62 (-3.21%)

TFX Teleflex
$308.95 /

+4 (+1.31%)

SNSE Sensei Biotherapeutics
$6.78 /

-0.79 (-10.44%)

SEER Seer
$21.53 /

-1.37 (-5.98%)

RVNC Revance
$12.45 /

-0.4 (-3.11%)

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

QDEL Quidel
$149.61 /

+5.01 (+3.46%)

PSNL Personalis
$13.74 /

-0.27 (-1.93%)

ONTX Onconova
$3.06 /

-0.11 (-3.47%)

NUVA NuVasive
$49.21 /

-1.4 (-2.77%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

HALO Halozyme
$33.31 /

-0.61 (-1.80%)

GBT Global Blood Therapeutics
$27.99 /

-1.375 (-4.68%)

FLDM Fluidigm
$4.51 /

-0.195 (-4.15%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

DMAC DiaMedica Therapeutics
$3.63 /

-0.135 (-3.59%)

DICE Dice Therapeutics
$31.39 /

-1.68 (-5.08%)

CYTK Cytokinetics
$38.79 /

-0.38 (-0.97%)

BXRX Baudax Bio
/

+

REGN Regeneron
$654.26 /

+9.38 (+1.45%)

IOVA Iovance Biotherapeutics
$18.26 /

-0.23 (-1.24%)

IMTX Immatics
$11.33 /

+0.05 (+0.44%)

DOCS Doximity
$66.69 /

+5.56 (+9.10%)

Monday
Conference/Events
Piper Sandler to hold a virtual conference » 10:34
11/29/21
11/29
10:34
11/29/21
10:34
ABEO

Abeona Therapeutics

/

+

, AQST

Aquestive Therapeutics

$6.27 /

-0.09 (-1.42%)

, BXRX

Baudax Bio

/

+

, CYTK

Cytokinetics

$39.93 /

+0.76 (+1.94%)

, CUE

Cue Biopharma

$12.79 /

-0.1 (-0.78%)

, DOCS

Doximity

$65.64 /

+4.51 (+7.38%)

, DMAC

DiaMedica Therapeutics

$3.78 /

+0.015 (+0.40%)

, DICE

Dice Therapeutics

$32.28 /

-0.79 (-2.39%)

, FLDM

Fluidigm

$4.50 /

-0.2 (-4.26%)

, GBT

Global Blood Therapeutics

$29.05 /

-0.315 (-1.07%)

, IMTX

Immatics

$11.32 /

+0.04 (+0.35%)

, HALO

Halozyme

$33.94 /

+0.02 (+0.06%)

, IOVA

Iovance Biotherapeutics

$18.40 /

-0.09 (-0.49%)

, MDXG

MiMedx

$7.39 /

+0.05 (+0.68%)

, NUVA

NuVasive

$51.00 /

+0.39 (+0.77%)

, ONTX

Onconova

$3.12 /

-0.05 (-1.58%)

, PSNL

Personalis

$13.73 /

-0.28 (-2.00%)

, QDEL

Quidel

$146.00 /

+1.4 (+0.97%)

, REGN

Regeneron

$647.50 /

+2.62 (+0.41%)

, RVNC

Revance

$12.80 /

-0.05 (-0.39%)

, SEER

Seer

$22.23 /

-0.67 (-2.93%)

, SNSE

Sensei Biotherapeutics

$7.80 /

+0.23 (+3.04%)

, TFX

Teleflex

$311.52 /

+6.57 (+2.15%)

, TNYA

Tenaya Therapeutics

$18.95 /

-0.37 (-1.92%)

, VIVO

Meridian Bioscience

$20.13 /

-0.07 (-0.35%)

33rd Annual Healthcare…

33rd Annual Healthcare Virtual Conference to be held on November 29-December 2.

ShowHide Related Items >><<
VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

TFX Teleflex
$311.52 /

+6.57 (+2.15%)

SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

SEER Seer
$22.23 /

-0.67 (-2.93%)

RVNC Revance
$12.80 /

-0.05 (-0.39%)

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

PSNL Personalis
$13.73 /

-0.28 (-2.00%)

ONTX Onconova
$3.12 /

-0.05 (-1.58%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

MDXG MiMedx
$7.39 /

+0.05 (+0.68%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

IMTX Immatics
$11.32 /

+0.04 (+0.35%)

HALO Halozyme
$33.94 /

+0.02 (+0.06%)

GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

CUE Cue Biopharma
$12.79 /

-0.1 (-0.78%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.27 /

-0.09 (-1.42%)

ABEO Abeona Therapeutics
/

+

ABEO Abeona Therapeutics
/

+

11/29/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $4 from $5 at H.C. Wainwright
07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
AQST Aquestive Therapeutics
$6.27 /

-0.09 (-1.42%)

06/24/21 Lake Street
Aquestive approval likely by year-end after Libervant NDA, says Lake Street
04/06/21 RBC Capital
Aquestive Therapeutics transferred with an Outperform at RBC Capital
BXRX Baudax Bio
/

+

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

11/04/21 H.C. Wainwright
Cytokinetics price target raised to $62 from $58 at H.C. Wainwright
10/12/21 Cantor Fitzgerald
Cytokinetics price target raised to $57 from $48 at Cantor Fitzgerald
10/06/21 Jefferies
Cytokinetics initiated with a Buy at Jefferies
10/04/21 Piper Sandler
Cytokinetics set to make commercial impact, says Piper Sandler
CUE Cue Biopharma
$12.79 /

-0.1 (-0.78%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
11/16/21 Baird
Doximity initiated with an Outperform at Baird
11/10/21 Needham
Doximity price target raised to $90 from $62 at Needham
11/10/21 Canaccord
Doximity price target raised to $75 from $70 at Canaccord
DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

09/27/21 Roth Capital
DiaMedica price target lowered to $24 from $32 at Roth Capital
06/30/21 Maxim
DiaMedica Therapeutics price target lowered to $11 from $14 at Maxim
06/29/21 Lake Street
DiaMedica should be bought on weakness after CKD data, says Lake Street
06/29/21 Roth Capital
DiaMedica Therapeutics price target lowered to $32 from $38 at Roth Capital
DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

10/11/21 SVB Leerink
Dice Therapeutics initiated with an Outperform at SVB Leerink
10/11/21 Evercore ISI
Evercore ISI starts Dice Therapeutics at Outperform, sees 120% upside
10/11/21 BofA
Dice Therapeutics initiated with a Buy at BofA
10/11/21 Evercore ISI
Dice Therapeutics initiated with an Outperform at Evercore ISI
FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

10/06/21 Jefferies
Global Blood Therapeutics initiated with a Buy at Jefferies
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
08/04/21 Truist
Global Blood Therapeutics upgraded to Buy from Hold at Truist
IMTX Immatics
$11.32 /

+0.04 (+0.35%)

03/17/21 Chardan
Immatics' early TCR platform activity signals 'notable,' says Chardan
03/17/21 SVB Leerink
Immatics price target raised to $26 from $17 at SVB Leerink
HALO Halozyme
$33.94 /

+0.02 (+0.06%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Evercore ISI
Halozyme initiated with an Outperform at Evercore ISI
06/11/21 BMO Capital
Halozyme coverage transferred at BMO Capital
05/17/21 SVB Leerink
Halozyme initiated with an Outperform at SVB Leerink
IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
06/29/21 Chardan
Iovance data show activity but 'not a home run,' says Chardan
MDXG MiMedx
$7.39 /

+0.05 (+0.68%)

07/26/21 Northland
MiMedx initiated with an Outperform at Northland
03/19/21 H.C. Wainwright
MiMedx initiated with a Buy at H.C. Wainwright
NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

11/15/21 Piper Sandler
Piper sees 'low' odds that Globus will try to buy NuVasive
11/10/21 Needham
NuVasive price target lowered to $64 from $73 at Needham
11/10/21 Citi
NuVasive price target lowered to $70 from $82 at Citi
10/28/21 Loop Capital
NuVasive initiated with a Hold at Loop Capital
ONTX Onconova
$3.12 /

-0.05 (-1.58%)

09/28/21 Guggenheim
Onconova price target lowered to $12 from $29 at Guggenheim
05/18/21 Guggenheim
Onconova initiated with a Buy at Guggenheim
12/22/20 Noble Capital
Onconova upgraded to Outperform from Market Perform at Noble Capital
PSNL Personalis
$13.73 /

-0.28 (-2.00%)

11/05/21 Morgan Stanley
Morgan Stanley downgrades Personalis, says upside unlikely until 2023
11/05/21 Morgan Stanley
Personalis downgraded to Equal Weight from Overweight at Morgan Stanley
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
11/03/21 Needham
Personalis downgraded to Hold from Buy at Needham
QDEL Quidel
$146.00 /

+1.4 (+0.97%)

10/08/21 JPMorgan
Quidel price target raised to $80 from $70 at JPMorgan
09/17/21 Raymond James
U.S. contract awards 'major wins' for Quidel, OraSure, says Raymond James
07/26/21 Piper Sandler
Quidel agreement with Beckman removes overhang, says Piper Sandler
07/19/21 Raymond James
Quidel contract with Delaware could increase materially, says Raymond James
REGN Regeneron
$647.50 /

+2.62 (+0.41%)

11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
11/09/21 Benchmark
Benchmark sees signs Regeneron may be planning large acquisition
RVNC Revance
$12.80 /

-0.05 (-0.39%)

10/26/21 Barclays
Revance price target lowered to $22 from $33 at Barclays
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/25/21 Wells Fargo
Revance downgraded to Equal Weight from Overweight at Wells Fargo
10/18/21 Needham
Revance price target lowered to $25 from $45 at Needham
SEER Seer
$22.23 /

-0.67 (-2.93%)

10/14/21 Cowen
Seer coverage transferred at Cowen
08/13/21 Morgan Stanley
Seer price target lowered to $50 from $55 at Morgan Stanley
12/29/20 BofA
BofA starts Seer with Neutral after 239% post-IPO rally
12/29/20
Fly Intel: Top five analyst calls
SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

07/06/21 Piper Sandler
Sensei Biotherapeutics price target lowered to $12 from $25 at Piper Sandler
07/05/21 AlphaValue/Baader
Sensei Biotherapeutics downgraded to Add from Buy at AlphaValue
07/01/21 Berenberg
Berenberg downgrades Sensei to Hold on 'significant setback'
07/01/21 Berenberg
Sensei Biotherapeutics downgraded to Hold from Buy at Berenberg
TFX Teleflex
$311.52 /

+6.57 (+2.15%)

11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TNYA Tenaya Therapeutics
$18.95 /

-0.37 (-1.92%)

10/25/21 Piper Sandler
Conviction in Tenaya Therapeutics stronger after ESGCT data, says Piper Sandler
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
08/24/21 Chardan
Tenaya Therapeutics initiated with a Buy at Chardan
08/24/21 Morgan Stanley
Tenaya Therapeutics initiated with an Overweight at Morgan Stanley
VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

02/24/21 H.C. Wainwright
Meridian Bioscience price target lowered to $32 from $34 at H.C. Wainwright
02/23/21 Piper Sandler
Piper keeps Overweight on Meridian Bioscience after EUA withdrawal
02/08/21 H.C. Wainwright
Meridian Bioscience price target raised to $34 from $30 at H.C. Wainwright
02/08/21 Piper Sandler
Meridian Bioscience price target raised to $34 from $26 at Piper Sandler
VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

TNYA Tenaya Therapeutics
$18.95 /

-0.37 (-1.92%)

TFX Teleflex
$311.52 /

+6.57 (+2.15%)

SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

SEER Seer
$22.23 /

-0.67 (-2.93%)

RVNC Revance
$12.80 /

-0.05 (-0.39%)

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

PSNL Personalis
$13.73 /

-0.28 (-2.00%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

IMTX Immatics
$11.32 /

+0.04 (+0.35%)

HALO Halozyme
$33.94 /

+0.02 (+0.06%)

GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

CUE Cue Biopharma
$12.79 /

-0.1 (-0.78%)

BXRX Baudax Bio
/

+

AQST Aquestive Therapeutics
$6.27 /

-0.09 (-1.42%)

ABEO Abeona Therapeutics
/

+

  • 24
    Sep
  • 15
    Sep
  • 30
    Jul
  • 21
    Jul
  • 24
    Jun
  • 11
    Feb
  • 04
    Feb
  • 27
    Jan
  • 28
    Jan
  • 04
    Dec
SEER Seer
$22.23 /

-0.67 (-2.93%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

VIVO Meridian Bioscience
$20.13 /

-0.07 (-0.35%)

TNYA Tenaya Therapeutics
$18.95 /

-0.37 (-1.92%)

TFX Teleflex
$311.52 /

+6.57 (+2.15%)

SNSE Sensei Biotherapeutics
$7.80 /

+0.23 (+3.04%)

SEER Seer
$22.23 /

-0.67 (-2.93%)

RVNC Revance
$12.80 /

-0.05 (-0.39%)

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

QDEL Quidel
$146.00 /

+1.4 (+0.97%)

PSNL Personalis
$13.73 /

-0.28 (-2.00%)

ONTX Onconova
$3.12 /

-0.05 (-1.58%)

NUVA NuVasive
$51.00 /

+0.39 (+0.77%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

HALO Halozyme
$33.94 /

+0.02 (+0.06%)

GBT Global Blood Therapeutics
$29.05 /

-0.315 (-1.07%)

FLDM Fluidigm
$4.50 /

-0.2 (-4.26%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

DMAC DiaMedica Therapeutics
$3.78 /

+0.015 (+0.40%)

DICE Dice Therapeutics
$32.28 /

-0.79 (-2.39%)

CYTK Cytokinetics
$39.93 /

+0.76 (+1.94%)

BXRX Baudax Bio
/

+

REGN Regeneron
$647.50 /

+2.62 (+0.41%)

IOVA Iovance Biotherapeutics
$18.40 /

-0.09 (-0.49%)

IMTX Immatics
$11.32 /

+0.04 (+0.35%)

DOCS Doximity
$65.64 /

+4.51 (+7.38%)

Over a week ago
On The Fly
Glaukos, iRhythm soar following updated Medicare reimbursement rates » 14:34
11/03/21
11/03
14:34
11/03/21
14:34
GKOS

Glaukos

$53.00 /

+7.88 (+17.46%)

, IRTC

iRhythm

$116.70 /

+39.96 (+52.07%)

, SGHT

Sight Sciences

$26.15 /

+0.08 (+0.31%)

, TFX

Teleflex

$345.80 /

-24.14 (-6.53%)

Shares of Glaukos (GKOS)…

ShowHide Related Items >><<
TFX Teleflex
$345.80 /

-24.14 (-6.53%)

SGHT Sight Sciences
$26.15 /

+0.08 (+0.31%)

IRTC iRhythm
$116.70 /

+39.96 (+52.07%)

GKOS Glaukos
$53.00 /

+7.88 (+17.46%)

GKOS Glaukos
$53.00 /

+7.88 (+17.46%)

11/03/21 Stephens
Glaukos upgraded to Overweight at Stephens after final CMS rules published
11/03/21 Stephens
Glaukos upgraded to Overweight from Equal Weight at Stephens
11/03/21 Piper Sandler
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler
10/14/21 JPMorgan
Glaukos price target lowered to $40 from $50 at JPMorgan
IRTC iRhythm
$116.70 /

+39.96 (+52.07%)

10/14/21 JPMorgan
iRhythm price target raised to $70 from $55 at JPMorgan
10/01/21 Citi
iRhythm price target raised to $60 from $55 at Citi
09/13/21 Baird
iRhythm's new COE has 'quality pedigree,' says Baird
09/13/21 Piper Sandler
DexCom COO departure won't affect momentum, says Piper Sandler
SGHT Sight Sciences
$26.15 /

+0.08 (+0.31%)

09/15/21 Piper Sandler
Piper says Glaukos patent settlement doesn't ease reimbursement challenges
08/09/21
Fly Intel: Top five analyst initiations
08/09/21 BofA
Sight Sciences initiated with a Buy at BofA
TFX Teleflex
$345.80 /

-24.14 (-6.53%)

10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
TFX Teleflex
$345.80 /

-24.14 (-6.53%)

IRTC iRhythm
$116.70 /

+39.96 (+52.07%)

GKOS Glaukos
$53.00 /

+7.88 (+17.46%)

  • 15
    Jul
  • 10
    Jun
IRTC iRhythm
$116.70 /

+39.96 (+52.07%)

SGHT Sight Sciences
$26.15 /

+0.08 (+0.31%)

IRTC iRhythm
$116.70 /

+39.96 (+52.07%)

GKOS Glaukos
$53.00 /

+7.88 (+17.46%)

Recommendations
Glaukos 'big beneficiary' of final CMS ruling, says Piper Sandler » 04:55
11/03/21
11/03
04:55
11/03/21
04:55
GKOS

Glaukos

$45.12 /

-1.2451 (-2.69%)

, SGHT

Sight Sciences

$26.19 /

-0.6 (-2.24%)

, TFX

Teleflex

$369.63 /

+10.055 (+2.80%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien says Glaukos (GKOS) "appears to be the big beneficiary" of the Centers for Medicare and Medicaid Services' Final Physician Fee, Hospital Outpatient, and Ambulatory Surgery Center Rules for 2022. The company's facility cut has been largely reversed and its physician cut reduced, O'Brien tells investors in a research note. The analyst says that while this may pressure Sight Sciences (SGHT) shares, he reminds investors that the rule still should put Sight in a better reimbursement position in 2022 than it was in 2021, "a year in which SGHT was a share-taker." In addition, the reduction in reimbursement for Teleflex's (TFX) Urolift was reduced from about down 20% to about down 10% in the final rule, which "should be sufficient to drive growth for that franchise," says O'Brien.

ShowHide Related Items >><<
TFX Teleflex
$369.63 /

+10.055 (+2.80%)

SGHT Sight Sciences
$26.19 /

-0.6 (-2.24%)

GKOS Glaukos
$45.12 /

-1.2451 (-2.69%)

GKOS Glaukos
$45.12 /

-1.2451 (-2.69%)

10/14/21 JPMorgan
Glaukos price target lowered to $40 from $50 at JPMorgan
09/15/21 Piper Sandler
Piper says Glaukos patent settlement doesn't ease reimbursement challenges
09/01/21 William Blair
CMS panel sides with Glaukos on all proposals, says William Blair
08/06/21 Piper Sandler
Glaukos price target lowered to $45 from $80 at Piper Sandler
SGHT Sight Sciences
$26.19 /

-0.6 (-2.24%)

08/09/21
Fly Intel: Top five analyst initiations
08/09/21 BofA
Sight Sciences initiated with a Buy at BofA
08/09/21 Citi
Sight Sciences initiated with a Buy at Citi
TFX Teleflex
$369.63 /

+10.055 (+2.80%)

10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
TFX Teleflex
$369.63 /

+10.055 (+2.80%)

GKOS Glaukos
$45.12 /

-1.2451 (-2.69%)

  • 15
    Jul
SGHT Sight Sciences
$26.19 /

-0.6 (-2.24%)

GKOS Glaukos
$45.12 /

-1.2451 (-2.69%)

Over a month ago
Earnings
Teleflex raises 2021 adjusted EPS view to $13.15-$13.35 from $12.90-$13.10 » 06:48
10/28/21
10/28
06:48
10/28/21
06:48
TFX

Teleflex

$366.33 /

-7.34 (-1.96%)

Consensus for 2021 EPS is…

Consensus for 2021 EPS is $12.98. Reduces 2021 GAAP revenue growth view to 10.00%-11.00% year-over-year from 10.50%-11.75% previously. On a constant currency basis, the Company reduced its 2021 revenue growth guidance range to 8.00%-9.00% from 8.50%-9.75% year-over year. Teleflex reduced its 2021 revenue growth guidance for the Interventional Urology business to 15% to 17% year-over-year. Consensus for 2021 revenue is $2.82B.

ShowHide Related Items >><<
TFX Teleflex
$366.33 /

-7.34 (-1.96%)

TFX Teleflex
$366.33 /

-7.34 (-1.96%)

10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
TFX Teleflex
$366.33 /

-7.34 (-1.96%)

Earnings
Teleflex reports Q3 adjusted EPS $3.51, consensus $3.03 » 06:45
10/28/21
10/28
06:45
10/28/21
06:45
TFX

Teleflex

$366.33 /

-7.34 (-1.96%)

Reports Q3 revenue…

Reports Q3 revenue $700.3M, consensus $698.26M. CEO Liam Kelly said, "Teleflex delivered solid Q3 results reflecting the benefits of our diversified product portfolio and disciplined operating execution, despite varying levels of headwinds associated with COVID-19 infections across our product lines and geographic segments. In the quarter, we generated double-digit constant currency revenue growth and a sequential improvement in operating margin, which led to $3.51 in adjusted EPS, up 27% year-over-year. UroLift witnessed a greater than expected impact from COVID-19 during Q3, including regional pauses in elective surgical procedures and business-related disruptions associated with the pandemic. For 2021, we are lowering our constant currency revenue guidance range and raising the full year adjusted EPS guidance range. Given our Q3 results and Q4 outlook, our 2021 revenue growth guidance for UroLift has been reduced to 15-17% year-over-year. Our revised outlook does not assume a full recovery in elective surgical procedures due to the ongoing impact of the COVID-19 pandemic."

ShowHide Related Items >><<
TFX Teleflex
$366.33 /

-7.34 (-1.96%)

TFX Teleflex
$366.33 /

-7.34 (-1.96%)

10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
TFX Teleflex
$366.33 /

-7.34 (-1.96%)

Downgrade
Fly Intel: Top five analyst downgrades » 09:57
10/07/21
10/07
09:57
10/07/21
09:57
ASX

ASE Technology

$7.22 /

-0.015 (-0.21%)

, TFX

Teleflex

$378.66 /

-0.1 (-0.03%)

, BOX

Box

$25.09 /

-0.275 (-1.08%)

, CTXS

Citrix

$104.66 /

-1.28 (-1.21%)

, ALLY

Ally Financial

$54.15 /

+0.46 (+0.86%)

Catch up on today's…

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. ASE Technology (ASX) downgraded to Neutral from Buy at Goldman Sachs with analyst Bruce Lu saying given the company's relatively higher mainland China presence, it faces higher downside risk for both its production linearity and revenue growth outlook. 2. Teleflex (TFX) downgraded to Sector Weight from Overweight at KeyBanc with analyst Matthew Mishan seeing less visibility into UroLift's long-term growth rate, which he thinks could have a broader impact on the company's overall financial profile and limit upside to its current valuation. 3. Box (BOX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Josh Baer saying the stock's over 45% of outperformance versus the small cap software group year-to-date reflects several quarters of "strong execution and the potential for continued acceleration." 4. Citrix (CTXS) downgraded to Neutral from Buy at Citi with analyst Tyler Radke saying the "sudden" departure of CEO David Henshall, just weeks ahead of the Q3 report and analyst day, suggests that the company is unlikely to be sold to a financial buyer and that its long-term targets "may be more unachievable with the analyst day pushed out." 5. Ally Financial (ALLY) downgraded to Equal Weight from Overweight at Stephens with analyst Vincent Caintic saying he thinks its tailwinds "have now shifted to idle" given the view that used car prices have peaked, auto originations may slow due to a lack of cars available to sell, and that higher interest rates are a slight negative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TFX Teleflex
$378.66 /

-0.1 (-0.03%)

CTXS Citrix
$104.66 /

-1.28 (-1.21%)

BOX Box
$25.09 /

-0.275 (-1.08%)

ASX ASE Technology
$7.22 /

-0.015 (-0.21%)

ALLY Ally Financial
$54.15 /

+0.46 (+0.86%)

ASX ASE Technology
$7.22 /

-0.015 (-0.21%)

10/07/21 Goldman Sachs
ASE Technology downgraded to Neutral from Buy at Goldman Sachs
06/25/21 Nomura
ASE Technology downgraded to Neutral from Buy at Nomura
TFX Teleflex
$378.66 /

-0.1 (-0.03%)

10/07/21 KeyBanc
KeyBanc downgrades Teleflex on lower UroLift visibility
10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
BOX Box
$25.09 /

-0.275 (-1.08%)

10/07/21 Morgan Stanley
Morgan Stanley downgrades Box on resumption after stock outperformance
10/07/21 Morgan Stanley
Box downgraded to Equal Weight from Overweight at Morgan Stanley
09/27/21
Fly Intel: Top five analyst upgrades
09/27/21 JMP Securities
Box upgraded to Outperform from Market Perform at JMP Securities
CTXS Citrix
$104.66 /

-1.28 (-1.21%)

10/07/21 Morgan Stanley
Citrix CEO exit may be followed by long-term strategy shift, says Morgan Stanley
10/07/21 Citi
Citrix downgraded to Neutral from Buy at Citi
07/30/21 MKM Partners
Upwork price target raised to $65 from $58 at MKM Partners
07/30/21 RBC Capital
Citrix price target lowered to $110 from $150 at RBC Capital
ALLY Ally Financial
$54.15 /

+0.46 (+0.86%)

10/07/21 Stephens
Stephens cuts Ally Financial to Equal Weight with unchanged $67 target
10/07/21 Stephens
Ally Financial downgraded to Equal Weight from Overweight at Stephens
07/22/21 Citi
Ally Financial price target raised to $63 from $59 at Citi
07/21/21 Deutsche Bank
Ally Financial price target raised to $70 from $65 at Deutsche Bank
TFX Teleflex
$378.66 /

-0.1 (-0.03%)

CTXS Citrix
$104.66 /

-1.28 (-1.21%)

BOX Box
$25.09 /

-0.275 (-1.08%)

ASX ASE Technology
$7.22 /

-0.015 (-0.21%)

ALLY Ally Financial
$54.15 /

+0.46 (+0.86%)

CTXS Citrix
$104.66 /

-1.28 (-1.21%)

BOX Box
$25.09 /

-0.275 (-1.08%)

CTXS Citrix
$104.66 /

-1.28 (-1.21%)

BOX Box
$25.09 /

-0.275 (-1.08%)

ALLY Ally Financial
$54.15 /

+0.46 (+0.86%)

CTXS Citrix
$104.66 /

-1.28 (-1.21%)

BOX Box
$25.09 /

-0.275 (-1.08%)

ASX ASE Technology
$7.22 /

-0.015 (-0.21%)

ALLY Ally Financial
$54.15 /

+0.46 (+0.86%)

Downgrade
KeyBanc downgrades Teleflex on lower UroLift visibility » 05:51
10/07/21
10/07
05:51
10/07/21
05:51
TFX

Teleflex

$378.77 /

+2.13 (+0.57%)

KeyBanc analyst Matthew…

KeyBanc analyst Matthew Mishan downgraded Teleflex to Sector Weight from Overweight without a price target. The analyst sees less visibility into UroLift's long-term growth rate, which he thinks could have a broader impact on the company's overall financial profile and limit upside to its current valuation. Investors have placed increased scrutiny on UroLift's quarterly trends in 2021 as, despite increasing direct-to-consumer investments, it has been just meeting expectations versus a history of consistent and material outperformance since it was acquired in the second half of 17, Mishan tells investors in a research note.

ShowHide Related Items >><<
TFX Teleflex
$378.77 /

+2.13 (+0.57%)

TFX Teleflex
$378.77 /

+2.13 (+0.57%)

10/07/21 KeyBanc
Teleflex downgraded to Sector Weight from Overweight at KeyBanc
09/07/21 Raymond James
Teleflex assumed with an Outperform at Raymond James
08/02/21 KeyBanc
Teleflex price target lowered to $439 from $448 at KeyBanc
07/19/21 SVB Leerink
Teleflex downgraded to Market Perform from Outperform at SVB Leerink
TFX Teleflex
$378.77 /

+2.13 (+0.57%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.